S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Raging Capital Management Supports Vote "FOR" Election of BlueMountain Capital's External Director Nominees at Taro Pharmaceutical Annual General Meeting of Shareholders (2013/9/4)|
|BlueMountain Capital Management and IsZo Capital To Update Shareholders Regarding Lawsuit Against Taro Pharmaceutical Industries, Call for the Resignation of External Directors (2014/1/31)|
|Glass Lewis Recommends Taro Shareholders Vote for the Two Incumbent External Directors (2013/9/4)|
|Glass Lewis Recommends Taro Pharmaceutical Shareholders Vote FOR BlueMountain Capital Management's External Director Nominees at Upcoming Extraordinary General Meeting (2014/3/18)|
|ISS Recommends Taro Pharmaceutical Shareholders Vote FOR BlueMountain Capital Management's External Director Nominees at Upcoming Extraordinary General Meeting (2014/3/17)|
|BlueMountain Capital Management Announces that ISS Recommends Taro Pharmaceutical Shareholders Vote FOR the BlueMountain External Director Nominees at Upcoming Annual General Meeting (2013/9/3)|
|BlueMountain Capital Management, LLC Urges Minority Shareholders of Taro Pharmaceutical Industries Ltd. to Vote FOR BlueMountain's Independent External Nominees to the Board of Taro and AGAINST the Re-Election of Incumbent External Directors and All Interested-Party Proposals Involving Executive and Director Compensation (2014/3/20)|
|Taro Provides Results for Quarter Ended June 2013 ()|
|IsZo Capital Urges Taro Board to Withdraw its Recommendation for the Re-Election of the Current Taro External Directors at 2013 Annual Shareholder Meeting; Supports Election of BlueMountain's Independent Nominees ()|
|Taro to Defer Annual General Meeting to September 12, 2013 ()|
Click above to view more mutual fund data and stats for taro - Taro Pharmaceutical Industries Ltd.